Heart Valve Critical Pathway and Heart Valve Clinic: Novel Benchmarks for Modern Management of Valvular Heart Disease.
Journal
Critical pathways in cardiology
ISSN: 1535-2811
Titre abrégé: Crit Pathw Cardiol
Pays: United States
ID NLM: 101165286
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
pubmed:
5
4
2021
medline:
9
11
2021
entrez:
4
4
2021
Statut:
ppublish
Résumé
The growing burden of valvular heart disease in Western countries represents a challenge for the daily clinical practice, especially in the light of the ever-increasing number of therapeutic options. The Euro Heart Survey showed that, among elderly subjects with severe, symptomatic valve dysfunction, surgery is denied for 33% of patients with aortic stenosis and for 50% of patients with mitral regurgitation. Current management (from diagnosis to follow-up) is often fragmented in multiple-sometimes unnecessary-steps. Such a "patchy" approach may translate into a suboptimal management, especially in the geriatric population. New healthcare models exist that can coordinate care, reduce fragmentation, limit costs and, ultimately, improve outcomes: the clinical pathways.
Identifiants
pubmed: 33813534
doi: 10.1097/HPC.0000000000000260
pii: 00132577-202109000-00003
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
126-133Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
d’Arcy JL, Prendergast BD, Chambers JB, et al. Valvular heart disease: the next cardiac epidemic. Heart. 2011;97:91–93.
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur Heart J. 2003;24:1231–1243.
Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease: the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012; 33: 2451–2496.
Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011.
Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714–2720.
Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358–1365.
Lancellotti P, Rosenhek R, Pibarot P, et al. ESC Working Group on Valvular Heart Disease position paper–heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34:1597–1606.
Rotter T, Kinsman L, James E, et al. The quality of the evidence base for clinical pathway effectiveness: room for improvement in the design of evaluation trials. BMC Med Res Methodol. 2012;12:80.
Rotter T, Kinsman L, James E, et al. The effects of clinical pathways on professional practice, patient outcomes, length of stay, and hospital costs: Cochrane systematic review and meta-analysis. Eval Health Prof. 2012;35:3–27.
De Belvis AG, Bucci S. Come organizzare l’assistenza del paziente per percorsi di cura L’esperienza presso la Fondazione Policlinico Universitario “A. Gemelli.” Vita e pensiero: Milano 2018 IV capitolo.
Casati G, Panella M, Di Stanislao F, et al. Gestione per processi professionali e percorsi assistenziali. Progetto Formazione Qualità ISS, ARM, MS Roma-Ancona. 3rd ed. 2005 Manuale I, pp 45–52.
Burlacu A, Covic A, Cinteza M, et al. Exploring current evidence on the past, the present, and the future of the heart team: a narrative review. Cardiovasc Ther. 2020;2020:9241081.
Lancellotti P, Rosenhek R, Pibarot P. Heart valve clinic: rationale and organization. Can J Cardiol. 2014;30:1104–1107.
Chambers JB, Prendergast B, Iung B, et al. Standards defining a ‘Heart Valve Centre’: ESC working group on valvular heart disease and European association for cardiothoracic surgery viewpoint. Eur Heart J. 2017;38:2177–2183.
Pierri MD, Capestro F, Zingaro C, Torracca L. The changing face of cardiac surgery patients: an insight into a Mediterranean region. Eur J Cardiothorac Surg. 2010;38:407–413.
Sündermann SH, Dademasch A, Seifert B, et al. Frailty is a predictor of short- and mid-term mortality after elective cardiac surgery independently of age. Interact Cardiovasc Thorac Surg. 2014;18:580–585.
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489–495.
Vellas B, Guigoz Y, Garry PJ, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;15:116–122.
Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305:50–58.
Mijnarends DM, Meijers JM, Halfens RJ, et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc. 2013;14:170–178.
Landi F, Calvani R, Cesari M, et al. Sarcopenia as the biological substrate of physical frailty. Clin Geriatr Med. 2015;31:367–374.
McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci. 2014;69:576–583.
Williams JB, Alexander KP, Morin JF, et al. Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery. Am J Cardiol. 2013;111:137–142.
Opolski MP, Staruch AD, Jakubczyk M, et al. CT Angiography for the detection of coronary artery stenoses in patients referred for cardiac valve surgery: systematic review and meta-analysis. JACC Cardiovasc Imaging. 2016;9:1059–1070.
Chambers JB, Lancellotti P. Heart valve clinics, centers, and networks. Cardiol Clin. 2020;38:65–74.
Iung B, Delgado V, Rosenhek R, et al.; EORP VHD II Investigators. Contemporary presentation and management of valvular heart disease: the EURObservational research programme valvular heart disease II survey. Circulation. 2019;140:1156–1169.
Prevale 2020: Programma Regionale Valutazione degli Esiti degli Interventi sanitari 2020. Available at https://www.dep.lazio.it/prevale2020/
Pavone N, Chiariello GA, Bruno P, et al. The “Heart Valve Clinic” pathway for the management of frail patients with valvular heart disease: from “One for All” to “All for One.” Crit Pathw Cardiol. 2019;18:61–65.